Laura Oliphant has sold AEHR and made no open-market buys since Jul 2021

Dr. Laura Oliphant is an accomplished technology executive and venture capital investor currently serving as Director at Aehr Test Systems (NASDAQ: AEHR)( With more than 25 years of experience in the semiconductor and technology industries, she spent 15 years as an Investment Director with Intel Capital, where she received Intel's highest achievement award in recognition of the strategic impact of her investments and helped deliver more than $1 billion in strategic and financial value( Following her tenure at Intel, she served as CEO of Translarity, an investor-backed semiconductor test startup focused on RF test applications, where she brought the business to revenue and positioned it for ongoing success(

Oliphant holds a Ph.D. in Chemical Engineering from the University of California, Berkeley, where her doctoral research focused on candidate batteries for electric vehicles, along with a master's degree in chemical engineering from UC Berkeley and a BE from Manhattan College( She also holds a certificate in fintech from the Massachusetts Institute of Technology and is a board leadership fellow of the National Association of Corporate Directors( In addition to her role at Aehr Test Systems, where she joined the board in 2019( Oliphant serves on the boards of BE Semiconductor Industries NV (a leading provider of semiconductor process equipment)( and several private companies including Novelda AS and Numascale AS( She is recognized as a member of the NACD Directorship 100, representing the highest-impact directors in the United States(

Written by Perplexity from public sources.